Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
Sanskriti Sasikumar, Antonio P. Strafella
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Parkinson disease-associated cognitive impairment
Dag Aarsland, Lucia Batzu, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 767
Parkinson disease-associated cognitive impairment

Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 75
Single-nucleus multi-omics of Parkinson’s disease reveals a glutamatergic neuronal subtype susceptible to gene dysregulation via alteration of transcriptional networks
E. Keats Shwab, Daniel Gingerich, Zhaohui Man, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Morphological basis of Parkinson disease-associated cognitive impairment: an update
K. A. Jellinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 8, pp. 977-999
Closed Access | Times Cited: 28
A transcriptomic atlas of the human brain reveals genetically determined aspects of neuropsychiatric health
Xavier Bledsoe, Eric R. Gamazon
The American Journal of Human Genetics (2024) Vol. 111, Iss. 8, pp. 1559-1572
Open Access | Times Cited: 6
Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always
W. R. Wayne Martin, John R. Younce, Meghan C. Campbell, et al.
Annals of Neurology (2022) Vol. 93, Iss. 1, pp. 184-195
Open Access | Times Cited: 25
Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease
Jingru Ren, Lei Yan, Hao Zhou, et al.
Neurobiology of Disease (2023) Vol. 185, pp. 106254-106254
Open Access | Times Cited: 14
Muscimol injection in the thalamic reticular nucleus reverts the effect of dopaminergic lesion on short-term memory in the rat globus pallidus externus
Evangelista-Arzate Christian Alexis, Mora-Zenil Janeth, Ramanan Daniel, et al.
Brain Research (2025), pp. 149495-149495
Closed Access
Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson’s disease
Seungbeom Seo, Yeo Jun Yoon, Sangwon Lee, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
Angenelle Eve Rosal, Sarah L. Martin, Antonio P. Strafella
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Johann Faouzi, Manuela Tan, Fanny Casse, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Mild cognitive impairment in Parkinson's disease: current view
K. A. Jellinger
Frontiers in Cognition (2024) Vol. 3
Open Access | Times Cited: 4
The Effect of Repetitive Transcranial Magnetic Stimulation Treatment on Plasma BDNF Concentration and Executive Functions in Parkinson’s Disease: A Theoretical Translational Medicine Approach
Gianna Carla Riccitelli, Riccardo Gironi, Giorgia Melli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1205-1205
Open Access
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks
K. A. Jellinger
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 498-498
Open Access | Times Cited: 10
Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
Khaled Radad, Rudolf Moldzio, Christopher Krewenka, et al.
Exploration of Neuroprotective Therapy (2023), pp. 24-46
Open Access | Times Cited: 9
A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson’s disease
Xi Chen, Yuhu Zhang
Neural Regeneration Research (2023) Vol. 19, Iss. 2, pp. 324-330
Open Access | Times Cited: 9
A general clinical overview of the non-motor symptoms in Parkinson’s disease: Neuropsychiatric symptoms
Lucia Batzu, Aleksandra Podlewska, Lucy L. Gibson, et al.
International review of neurobiology (2024), pp. 59-97
Closed Access | Times Cited: 3
Neuroimaging outcomes associated with mild cognitive impairment subtypes in Parkinson's disease: A systematic review
Quentin Devignes, Renaud Lopes, Kathy Dujardin
Parkinsonism & Related Disorders (2022) Vol. 95, pp. 122-137
Closed Access | Times Cited: 14
Effectiveness of Cognitive Rehabilitation in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Itsasne Sanchez-Luengos, Yolanda Balboa-Bandeira, Olaia Lucas‐Jiménez, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 5, pp. 429-429
Open Access | Times Cited: 19
Transcranial direct current stimulation for Parkinson’s disease: systematic review and meta-analysis of motor and cognitive effects
Zhuo Duan, Chencheng Zhang
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Hippocampal correlates of episodic memory in Parkinson’s disease: A systematic review of magnetic resonance imaging studies
Dana Pourzinal, Jihyun Yang, Arnold Bakker, et al.
Journal of Neuroscience Research (2021) Vol. 99, Iss. 9, pp. 2097-2116
Open Access | Times Cited: 14
EEG Frequency Correlates with α2-Receptor Density in Parkinson’s Disease
Adam F. Kemp, Martin Byskov Kinnerup, Birger Johnsen, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 209-209
Open Access | Times Cited: 1
Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer’s and Lewy Body Spectra in the COMPASS-ND Study
H. Sebastian Caballero, G. Peggy McFall, Myrlene Gee, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 2, pp. 579-601
Closed Access | Times Cited: 1
Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort
Xi Chen, Chentao He, Jianrui Ma, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 8
Open Access | Times Cited: 1
The Role of CXCL12/CXCR4/CXCR7 Axis in Cognitive Impairment Associated with Neurodegenerative Diseases
Rojin Sarallah, Shima Jahani, Alireza Soltani Khaboushan, et al.
Brain Behavior & Immunity - Health (2024) Vol. 43, pp. 100932-100932
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top